February 12, 2021 at 14:30
“A novel fluid-dynamic Multi-In Vitro Organ-MIVO device for 3D culture and testing of molecules/drugs.”
– – –
Dr. Silvia Scaglione, PhD
Recently, 3D in vitro cancer models have become important alternatives to animal tests for establishing the efficacy of anticancer treatments. The MIVO® technology provides an in vitro fluidic multi-chamber platform for more reliable 3D fluid-dynamic assays to improve the effectiveness of pharmaceutical tests, discover innovative therapeutic approaches, and reduce animal testing.
It can easily accommodate and cultivate under sterile conditions commercial 3D human reconstructed tissues (e.g. epidermis, the vascular wall, small intestine), biopsies of different shape and thickness or cellularized membranes to suit your testing needs.
MIVO® provides a multiple fluidic circulation and multi-chamber system for culturing cells in vitro resembling the real tissues complexity.
– – –
Silvia Scaglione graduated in Biomedical Engineering at the University of Genoa, Italy. She obtained the PhD in Bioengineering and Bioelectronics at the University of Genoa. After a post-doc experience at the Advanced Biotechnology Center of Genoa, Italy, Silvia Scaglione is currently Researcher at National Council of Research (CNR), IEIIT Institute of Genoa, Italy. In 2016 she co-founded React4life, an innovative startup company with a consolidated expertise in the field of tissue engineering, bioengineering, regenerative medicine, informatics and entrepreneurship.